CHAPTER - 4 Material and Methods
CHAPTER - 4
Material and Methods
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 65
Materials
i) Drugs
Carbamazepine (Intas Pharmaceuticals, Ahmedabad, India), Phenytoin (Anglo French
Drugs and Industries Ltd., Bangalore, India), Vitamin C (Qualigens Fine Chemicals,
Mumbai, India), Vitamin E (E. Merck, Mumbai, India), Alpha Lipoic Acid (Sami
Labs, Bangalore, India), N Acetyl Cysteine (Fourts India laboratories, Pvt. Ltd, Tamil
Nadu, India).
ii) Chemicals
Tris buffer, ethylenediamine tetra acetate (EDTA), Pyrogallol, hydrogen peroxide,
trichloro acetic acid (TCA), Ellman’s reagent (Hi- Media Laboratories, Mumbai,
India), 5,5-dithiobis-2-nitrobenzoic acid (DTNB), sodium citrate, Dinitro phenyl
hydrazine (DNPH), thiourea, H2SO4, methanol, diphenyl picryl hydrazine (DPPH),
thio barbituric acid (TBA) (Himedia Laboratories, Mumbai, India), 1, 1, 3,
3-tetraethoxypropane, paraformaldehyde, acetyl thiocholine (Sigma Aldrich), HPLC
grade methanol (E. Merck, Mumbai, India), HPLC grade ethyl acetate (E. Merck,
Mumbai, India), HPLC grade glacial acetic acid (S.D. Fine Chem Ltd., Mumbai,
India).
iii) Assay Kits
SGOT, SGPT, bilirubin, ALP, albumin, total protein, TC, HDL, TG, blood glucose
estimation kits (AGAPPE, India).
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 66
iv) Instrumentation
Rota-Rod (INCO, Ambala, India), Hole board, Actophotometer (INCO, Ambala,
India), Elevated plus maze, Autoanalyser (Chemistry Analyser (CA 2005), B4B
Diagnostic Division, China), Automated Haematology Analyzer XT-1800i (Sysmex),
UV-visible, Shimadzu 1601 Spectrophotometer, Digital balance, Tissue homogenizer
RQ 127A (REMI Motors Ltd., Mumbai), Centrifuge (REMI Motors Ltd., Mumbai),
micropipettes (20 µl, 100 µl, 200 µl and 1000 µl).
HPLC system consisted of LC-8A solvent delivery module (Shimadzu, Kyoto, Japan),
SPD-10AVP UV-Visible Spectrophotometric detector, Chromotech N 2000, China
(soft ware), Rheodyne Injection Port (Rheodyne, Cotati, CA USA) with a 20 µl
sample loop and reverse phase C18 column (Grace-alltima, USA Inc., 250 x 4.6 mm,
5µm). Hamilton syringe 50 µl (Switzerland), Cyclomixer (Remi Equipments,
Mumbai, India), Biofuge Fresco centrifuge (Heracus, Germany), cooling centrifuge
(Remi Instruments, Mumbai, India), Ultra sonicator and Electrically heated water bath
were used.
Animals
Pathogen free adult male albino rats weighing 150-200 g were used. The rats were
housed in polypropylene cages at room temperature (25 ± 3oC) with 12/12 hours light
and dark cycle and were fed with a balanced diet and tap water ad libitum. The study
protocol was approved by the Institutional Animal Ethical Committee of M.S.
Ramaiah College of Pharmacy, Bangalore, Karnataka (Ref. No. MSRCP/P-09/2009,
Reg.No. 220/abc/CPCSEA).
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 67
Study Protocol
The rats were divided into fourteen groups; each group consisted of twelve animals.
Six out of twelve animals were used for the assessment of behavioural,
haematological and biochemical parameters. After the collection of blood samples on
45th day, the animals were sacrificed, liver and brain were harvested for further
histopathological analysis. The other six animals were subjected to investigation of
pharmacokinetic and pharmacodynamic interactions i.e the animals were subjected to
maximal electro shock after which blood samples were collected for estimation of
serum CBZ concentration.
Control group: Received 0.2% carboxy methyl cellulose (CMC) orally for 45 days.
CBZ group: Received CBZ (50 mg/Kg p.o) daily for 45 days.
Low dose Vit C group: Received co-administration of 50 mg/Kg of Vit C p.o, daily
for 45 days along with CBZ (50 mg/Kg).
Medium dose Vit C group: Received supplementation of 100 mg/Kg of Vit C p.o,
daily for 45 days along with CBZ (50 mg/Kg).
High dose Vit C group: Received 200 mg/Kg of Vit C p.o, daily for 45 days along
with CBZ (50 mg/Kg).
Low dose Vit E group: Received 50 mg/Kg of Vit E in 0.2% CMC orally for 45 days
daily along with CBZ (50 mg/Kg).
Medium dose Vit E group: Received 100 mg/Kg of Vit E in 0.2% CMC orally for
45 days along with CBZ (50 mg/Kg).
High dose Vit E group: Received 200 mg/Kg of Vit E in 0.2% CMC orally for 45
days with CBZ (50 mg/Kg).
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 68
Low dose ALA group: Received 50 mg/Kg of ALA in 0.2% CMC orally for 45 days
along with CBZ (50 mg/Kg).
Medium dose ALA group: Received 100 mg/Kg of ALA in 0.2% CMC orally for 45
days along with CBZ (50 mg/Kg).
High dose ALA group: Received 200 mg/Kg of ALA in 0.2% CMC orally for 45
days along with CBZ (50 mg/Kg).
Low dose NAC group: Received 50 mg/Kg of NAC p.o, daily for 45 days along with
CBZ (50 mg/Kg).
Medium dose NAC group: Received 100 mg/Kg of NAC p.o, daily for 45 days
along with CBZ (50 mg/Kg).
High dose NAC group: Received 200 mg/Kg of NAC p.o, daily for 45 days along
with CBZ (50 mg/Kg).
The dose of CBZ and antioxidants were chosen from previous investigations. CBZ
(Thaakur and Puspha, 2008), Vit C (Alsaif, 2009; Shahidi, et al., 2008; Afkhami-
Ardekani and Shojaoddiny-Ardekani, 2007), Vit E (Cadenas, et al., 1995; Naghibi, et
al., 2006), ALA (Pari and Murugavel, 2004; Thaakur and Himabindhu, 2009;
Arivazhagan, et al., 2006), NAC (Prakash and Kumar, 2009; Kamalakkannan, et al.,
2005; Raza, et al., 2003).
The animals (six out of twelve) were subjected to the following behavioural tests on
0, 15th, 30
th and 45
th day. Only one behavioural parameter was assessed at a given
time. The behavioural parameters were analyzed between 9.00 to 11.00 A.M.
Memory was assessed using Elevated Plus Maze, motor co-ordination was studied
using Rota Rod, locomotor activity was assessed with Actophotometer and alertness
was evaluated using Hole Board apparatus. On 45th day, after the investigation of
behavioural parameters the blood samples were collected from retro orbital plexus
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 69
under light ether anaesthesia for the estimation of enzymatic and non enzymatic
antioxidants, MDA content, total antioxidant status, liver enzymes, bilirubin, total
protein, albumin, LDL, HDL, VLDL, TG, blood glucose along with haematological
profiles which included the estimation of total RBC, total WBC, platelet count,
haemoglobin content and packed cell volume.
The animals were then sacrificed and the brain and liver were isolated, rinsed with
cold phosphate buffer (100 mM, pH 7.4), weighed, sliced for histopathological studies
and stored at -40ºC. The stored tissues were homogenized and the homogenate was
centrifuged at 10,000 rpm for 10 minutes at 4°C and was used for the estimation of
lipid peroxidation.
The other six animals were treated with CBZ and antioxidants according to the above
protocol for 45 days. On 45th
day, three hours after the last dose of CBZ and
antioxidant supplementation the animals were subjected to maximal electro shock
(MES) induced convulsions to compare the degree of protection offered by CBZ in
CBZ alone treated group and groups subjected to combination of CBZ and
antioxidants. Immediately after MES the blood samples were collected from retro
orbital plexus under light ether anaesthesia for the estimation of serum CBZ level.
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 70
Work Plan
Selection of antioxidants
Investigation of influence of selected antioxidants on the adverse
effects of CBZ
Vitamin C Vitamin E
Alpha Lipoic Acid N Acetyl Cysteine
1. Parameters to
assess
haematotoxicity
2. Parameters to
assess behavioural
abnormalities
3. Parameters
to assess
hepatotoxicity
4. Parameters to
assess metabolic
disorder
5. Investigation of
pharmacokinetic
& pharmacodynamic
interaction
Control
Study Protocol
CBZ
(50 mg/Kg)
Vitamin C Vitamin E
Alpha Lipoic Acid N Acetyl Cysteine
50 mg/Kg
100 mg/Kg
200 mg/Kg
50 mg/Kg
100 mg/Kg
200 mg/Kg
50 mg/Kg
100 mg/Kg
200 mg/Kg
50 mg/Kg
100 mg/Kg
200 mg/Kg
Estimation
1.2 Antioxidants
1.2.1 Enzymatic antioxidants i) Superoxide dismutase
ii) Catalase
1.2.2 Non-enzymatic antioxidants i)Reduced glutathione
ii) Vitamin C
1.2.3 Total antioxidant status
1.2.4 Lipid peroxidation
1. PARAMETERS TO ASSESS HAEMATOTOXICITY
1.1 Estimation of
Haematological
Profile
i) Haemoglobin
ii) Total erythrocyte
iii) Total leukocyte
iv) Platelet count
v) Packed cell volume
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 71
2. PARAMETERS TO ASSESS BEHAVIOURAL ABNORMALITIES
2.1 Assessment of
behavioural
parameters
i) Motor co-ordination test
ii) Test for alertness
iii) Test for memory
impairment
iv) Test for locomotor activity
2.2 Assessment of
oxidative stress in
brain tissues
Regional brain lipid
peroxidation
2.3 Brain
Histopathology
3. PARAMETERS TO ASSESS HEPATOTOXICITY
3.1 Assessment of liver
function test
i) SGPT
ii) SGOT
iii) ALP
v) Bilirubin
vi) Total protein v) Albumin
3.2 Assessment of
oxidative stress in liver i) Liver lipid peroxidation
3.3 Liver
histopathology
4. PARAMETERS TO ASSESS METABOLIC DISORDER
4.1 Blood glucose
estimation
4.2 Assessment of lipid
profile
i) Total cholesterol
ii) Triglycerides
iii) HDL
vi) LDL
v) VLDL
5. INVESTIGATION OF PHARMACOKINETIC
& PHARMACODYNAMIC INTERACTION
5.1 Maximal electroshock
induced seizures
5.2 Estimation of plasma
CBZ concentration by
HPLC method
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 72
1. PARAMETERS TO ASSESS HAEMATOTOXICITY
1.1 Assessment of Haematological profile
Haematological parameters include haemoglobin estimation, total erythrocyte, total
leukocyte and platelet count along with packed cell volume using Automated
Haematology Analyzer XT-1800i (Sysmex, USA).
1.2 Assessment of antioxidant status
1.2.1 Estimation of enzymatic antioxidants
i) Superoxide dismutase
Principle: Assay of superoxide dismutase (SOD) was based on the ability of the
enzyme to inhibit the autooxidation of pyrogallol.
The assay was performed by using 1.5 ml tris buffer (0.05 M) and 0.5ml EDTA
(1 mM) as blank. 1.5 ml tris buffer, 0.5 ml EDTA (1 mM) and 1 ml pyrogallol (0.2
mM) as control and the test sample consisted of 1.5 ml tris buffer (0.05 M), 0.5 ml
EDTA (1 mM), 0.05 ml serum and 1 ml pyrogallol (0.2 mM). Change in optical
absorbance of sample per minute with reference to blank was recorded at a
wavelength of 420 nm using SICO Spectrophotometer. The enzyme inhibition caused
by the serum was calculated and the enzyme activity was expressed as superoxide
anion reduced/mg protein/min (Marklund and Marklund, 1974).
ii) Catalase
Principle: Catalase (hydrogen peroxide oxidoreductase) catalyzes the following
reactions.
Decomposition of H2O2 to form H2O and O2
2 H2O2 2 H2O + O2 Catalase
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 73
Catalase activity is measured either by decomposition of H2O2 or by liberation of O2.
The decrease in the absorbance by H2O2 as a function of time is used to follow the
catalase-peroxide reaction. The spectral region for hydrogen peroxide is 210-240 nm.
The difference in absorbance per minute is a measure of catalase activity.
2.5 ml of phosphate buffer was added to 0.1 ml of serum and incubated at 25°C for 30
min. After transferring into a cuvette the absorbance was measured at 240 nm, 650 µl
of hydrogen peroxide solution was added to initiate the reaction, the change in
absorbance was measured for 3 min (Beer and Sizer, 1952).
1.2.2 Estimation of non-enzymatic antioxidants
i) Reduced glutathione
Principle: The most widely used method for the determination of GSH in biological
samples is by Ellman reagent (DTNB), which reacts with sulfydryl compounds to
give a relatively stable yellow color. This compound is water soluble and the color
formed is proportional to the amount of GSH.
To 0.5 ml of citrated blood, 0.5 ml of 5% trichloro acetic acid (TCA) solution was
added to precipitate the proteins and centrifuged at 3000 rpm for 20 min. To 0.1 ml of
supernatant, 1 ml of sodium phosphate buffer and 0.5 ml of DTNB reagent was
added. The absorbance of the yellow color developed was measured at 412 nm
(Ellman, 1959).
ii) Vitamin C
To 0.5 ml of plasma, 1.5 ml of 6% TCA was added and centrifuged at 3500 rpm for
20 min. To 0.5 ml of the supernatant, 0.5 ml of DNPH reagent (2 % DNPH and 4 %
thiourea in 9 N H2SO4) was added and developed colour was read at 530 nm after 30
min (Omaye, et al., 1979).
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 74
1.2.3 Total antioxidant status
0.1 ml of serum was deproteinated by the addition of 1 ml of methanol, vortexed for
30 s. It was then centrifuged at 3000 rpm for 30 min to separate the proteins. To the
clear supernatant 1.5 ml of methanol and 0.5 ml of DPPH solutions were added,
mixed thoroughly and absorbance was read at 517 nm against blank. Blank was
prepared in an identical way but without the addition of serum (Blois, 1958).
1.2.4 Estimation of extent of oxidative stress in blood
i) Determination of MDA content (Lipid peroxidation)
0.1 ml of plasma was treated with 2 ml of TBA 0.37%, 0.25 N HCl and 15% TCA
(1:1:1) and heated in water bath for 15 min, cooled and centrifuged and then clear
supernatant was measured at 535 nm against reference blank (Niehaus and
Samuelson, 1968).
2. PARAMETERS TO ASSESS BEHAVIOURAL ABNORMALITIES
2.1 Assessment of behavioural parameters
i) Motor co-ordination test
Motor co-ordination test was conducted in rats using a Rota-Rod apparatus (Inco-
Ambala, India). The animals were screened for motor co-ordination and the animals
which stayed on the rotating rod without falling for 120 sec were chosen for the study.
Each animal was placed on the Rota rod and the time taken by the animal to fall down
was noted (Kulkarni, 1999).
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 75
ii) Test for alertness (Exploratory Behaviour)
This test was done using Hole Board, which consisted of a 0.5 m3 wooden board with
16 holes (3 cm in diameter). Each rat was placed individually on the board for a
period of 6 minutes. In first 2 minutes the animal was allowed for acclimatization and
then the number of head dipping performed in the next 4 minutes was noted for each
animal (Takeda, et al., 1998).
iii) Test for memory impairment
Elevated plus maze test was used for the assessment of memory. The elevated plus
maze consists of two closed arms and two open arms forming a cross, with a
quadrangular centre and has a height of 50 cm. The rats were placed individually at
the end of one open arm facing away from central platform and the time it took to
move from the open arm to either of the enclosed arms (transfer latency) was recorded
on the day of acquisition trial. Transfer latency is the time taken by the rats to move
from one end of the open arm to enclosed arm. The rat was allowed to move freely in
the plus maze regardless of open and closed arms for 10 sec after the measurement of
transfer latency. The rat was then gently taken out of the plus maze and was returned
to its home cage. On the test day, the transfer latency test was performed in the same
manner as in the acquisition trial (Sharma and Kulkarni, 1992).
iv) Test for locomotor activity
Spontaneous motor activity was monitored using Actophotometer. Each animal was
subjected to an adaptation period of 2-5 minutes, because the first measure of
animal’s activity is the rate of habituation to a novel environment. Thus, during
prolonged exposure to a new environment, animals typically spend less time in
movement and exploration, so the second measure was considered as the rate of
spontaneous activity of the rats. The counting was started following 5 minutes of
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 76
adaptation period. Increase in count was regarded as central nervous system stimulant
activity. Decrease in count was considered as central nervous system depressant
activity (Kulkarni, 1999).
2.2 Assessment of oxidative stress in brain tissues
The brains were quickly removed, cleaned with chilled saline, dissected into cortex,
midbrain, medulla, pons and cerebellum according to the method of Glownski and
Iversen (1966). The separated brain regions were stored at −40°C, homogenized and
regional brain lipid peroxidation was estimated.
i) Estimation of lipid peroxidation in brain regions
The extent of lipid peroxidation in tissues was assessed by measuring the level of
MDA according to the method of Ohkawa, et al., (1979). Briefly, 1 ml (10%) tissue
homogenate was added to the reaction mixture containing 1 ml of TCA (15%) and 2
ml of TBA (0.38%). The reaction mixture was heated for 60 min at 90o
C, cooled and
centrifuged at 6900 rpm for 15 min. The absorbance of supernatant was measured at
532 nm against blank, which contained all reagents except homogenate. MDA was
quantified and expressed as μmol of MDA per mg of wet tissue (Ohkawa, et al.,
1979).
2.3 Histopathological investigation on brain tissues
Brain tissues were dissected out carefully and were kept in 10% formalin solution
prepared with normal saline. Histopathological studies were conducted by Dr. Kishore
Alwa, Isha Diagnostics, Malleswaram, Bangalore. Tissues were stained using
Hematoxylin and Eosin stain (H and E).
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 77
i) Processing of isolated brain: The animals were sacrificed and the brain of each
animal was isolated. The isolated brain was cut into small pieces and fixed in 10%
formalin for two days. The brain pieces were washed in running water for about 12
hours. This was followed by dehydration with isopropyl alcohol of increasing strength
(70%, 80% and 90%) for 12 h each. Then the final dehydration was carried out using
absolute alcohol with about three changes for 12 h each. The clearing was done by
using chloroform with two changes for 15 to 20 min each. After clearing, the brain
pieces were subjected to paraffin infiltration in automatic tissue processing unit. The
brain pieces were washed with running water to remove formalin completely. To
remove the water, alcohol of increasing strengths was used. Further alcohol was
removed by using chloroform and chloroform was removed by paraffin infiltration.
ii) Embedding in paraffin vacuum: Hard paraffin was melted and the hot paraffin
was poured into L-shaped blocks. The brain pieces were then dropped into the molten
paraffin quickly and allowed to cool.
iii) Sectioning: The blocks were cut using microtone to get sections of 5 m
thickness. The sections were taken on a micro slide on which egg albumin (sticking
substance) was applied. The sections were allowed to remain in an oven at 60o
C for 1
hour. Paraffin melts and egg albumin denatures, thereby fixes tissues to slide.
iv) Staining: Eosin is an acid stain. Hence it stains all the cell constituents pink
which are basic in nature, like Cytoplasm. Haematoxyllin basic stain, stains acidic cell
components blue (e.g) DNA.
v) Procedure: The sections were deparaffinized, by washing with chloroform, for
about 15 min. They were then hydrated by washing in isopropyl alcohol of decreasing
strength (100%, 90%, 80%, 70%), followed by washing with water. The sections were
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 78
then stained with hemotoxylin for 15 min. After 15 min they were rinsed in tap water.
The sections were then differentiated in 1% acid alcohol by 10 quick dips. The
differentiation was examined under a microscope. Again the sections were washed in
tap water and dipped in lithium carbonate until they become bright blue (3-5 dips).
This was followed by washing in running tap water for 10 to 20 min, if washing is
inadequate eosin does not stain evenly. Eosin staining was done for 15 seconds to 2
min depending on the age of the eosin and the depth of the counter stain desired. For
even staining results, the slides were dipped several times before allowing them to set
in the eosin for the desired time. They were dehydrated in 95% isopropyl and absolute
isopropyl alcohol, until excess eosin was removed and mounted in Desterene dibutyl
phthalate xylene (Li, et al., 1998; Luna, 1986).
3. PARAMETERS TO ASSESS HEPATOTOXICITY
3.1 Assessment of liver function test
Serum was separated by centrifuging blood at 2500 rpm for 10 minutes and the levels
of SGOT, SGPT, bilirubin, ALP, albumin and total protein were analyzed by using a
commercially available enzymatic kit (AGAPPE, India) and an autoanalyser
(Chemistry Analyser (CA 2005), B4B Diagnostic Division, China).
i) Estimation of Serum Glutamate Pyruvate Transaminases (SGPT/ ALT)
Principle: Alanine aminotransferase catalyses the transfer of amino group from
alanine to 2-oxoglutarate, resulting in the formation of pyruvate and glutamate. The
catalytic concentration is determined from the rate of decrease of NADH, measured at
340 nm, by means of lactate dehydrogenase coupled reaction (Gella, et al., 1985)
The enzymatic reaction employed in the assay of SGPT is as follows:
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 79
L- Alanine + 2-oxoglutarate Pyruvate + L- Glutamate
Pyruvate + NADH+ H+ D- Lactate + NAD
+
Reagent Preparation
Reagent A: Tris-150 mmol/l, L-Alanine-750 mmol/l, Lactate dehydrogenase >1350
U/l, pH-7.3.
Reagent B: NADH-1.3 mmol/l, 2-oxoglutarate-75 mmol/l, Sodium hydroxide-148
mmol/l, Sodium azide-9.5 g/l.
Auxillary Reagent – Reagent C: Pyridoxal phosphate-10 mmol/l.
Working Reagent: Reagent A (4 parts) is mixed with 1 part of Reagent B. The
combined reagent was stable for 2 months at 2-8° C. The mixed reagent was stored in
a dark place and protected from light.
Working Reagent with Pyridoxal phosphate: 10ml of working reagent was mixed with
0.1 ml of reagent C. The solution was stable for 6 days at 2-8° C.
Procedure: Animal serum was used as the sample. 50 µl of serum was mixed with
1000 µl of mixed reagent and estimated in kinetic mode using a Biochemical
Analyzer.
Calculations
SGPT/ ALT concentration (U/l ) = delta A/min x Vt x 106
Ε x L x Vs
Molar absorbance (E) of NADH at 340 nm is 6300
L - Light path 1cm
ALT
LDH
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 80
Vt - Total reaction volume is 1.05 at 37° C
Vs - Sample volume is 0.05 at 37° C
ii) Estimation of Serum Glutamate Oxaloacetate Transaminases (SGOT/
AST)
Principle: Aspartate aminotransferase catalyzes the transfer of the amino group from
aspartate to 2-oxoglutarate, forming oxaloacetate and glutamate. The catalytic
concentration is determined from the rate of decrease of NADH, measured at 340 nm,
by means of malate dehydrogenase (MDH) coupled reaction (Gella, et al., 1985).
The enzymatic reaction employed in the assay of SGOT is as follows.
2-oxoglutarate Glutamate + Oxaloacetate
Oxaloacetate + NADH+ H+ D-Malate + NAD
+
Reagent Preparation
Reagent A: Tris 121 mmol/l, L- aspartate 362 mmol/l, malate dehydrogenase >460
U/l, lactate dehydrogenase > 660 U/l, sodium hydroxide 255 mmol/l, pH 7.8.
Reagent B: NADH 1.3 mmol/l, 2-oxoglutarate 75 mmol/l, sodium hydroxide
148 mmol/l, sodium azide 9.5 g/l.
Auxillary Reagent – Reagent C: Pyridoxal phosphate 10 mmol/l.
Working Reagent: Reagent A (4 parts) is mixed with 1 part of Reagent B. The
combined reagent is stable for 2 months at 2-8° C. The mixed reagent was stored
protected from light.
MDH
AST
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 81
Working Reagent with Pyridoxal phosphate: 10ml of working reagent was mixed with
0.1 ml of reagent C. Stable for 6 days at 2-8° C. Animal serum was used as the
sample.
Procedure: 50 µl of serum was mixed with 1000 µl of mixed reagent and estimated
in kinetic mode using a Biochemical Analyzer.
Calculations
SGOT/ AST concentration (U/l ) = delta A/min x Vt x 106
Ε x L x Vs
Molar absorbance (E) of NADH at 340 nm is 6300
L - Light path 1cm
Vt - Total reaction volume is 1.05 at 37° C
Vs - Sample volume is 0.05 at 37° C
iii) Estimation of Alkaline Phosphatase
Principle
Alkaline Phosphatase catalyses in alkaline medium the transfer of phosphate group
from 4-nitrophenyl phosphate to 2-amino-2-methyl-1-propanol, liberating
4-nitrophenol. The catalytic concentration is determined from the rate of
4-nitrophenol formation, measured at 405 nm (Rosalki, et al., 1993).
The enzymatic reaction employed in the assay of Alkaline Phosphatase is as follows:
4- Nitrophenyl phosphate + H2O Phosphate + 4- Nitrophenol
Reagents
Reagent A:
2- Amino-2- methyl- 1- propanol 0.4 mol/l
ALP
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 82
Zinc sulphate 1.2 mmol/l
N hydroxy ethylene diamine tri aceticacid 2.5 mmol/l
Magnesium acetate 2.5 mmol/l, pH 10.4.
Reagent B
4- Nitrophenyl phosphate 60 mmol/l.
Working Reagent: 4 parts of Reagent A is mixed with 1 part of Reagent B. The
combined reagent is stable for 2 months at 2-8° C.
Animal serum was used as the sample.
20 µl of serum was mixed with 1000 µl of mixed reagent and estimated in kinetic
mode using a Biochemical Analyzer.
Calculations
ALP concentration (U/l) = delta A/min x Vt x 106
Ε x L x Vs
Molar absorbance (E) of NADH at 405 nm is 18450
L- Light path 1cm
Vt - Total reaction volume is 1.02 at 37° C
Vs - Sample volume is 0.02 at 37° C
iv) Total bilirubin
Principle: Direct bilirubin in the sample reacts with diazotised sulfanilic acid forming
a coloured complex that can be measured by spectrophotometry. Both direct and
indirect bilirubin couple diazo in the presence of cetrimide (Pearlman and Lee, 1974).
The terms direct and total refer to the reaction characteristics of serum bilirubin in the
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 83
absence or presence of solubilizing reagents. The direct and indirect bilirubin is
approximately equivalent to the conjugated and unconjugated fractions.
Composition
Bilirubin (Total)
Reagent A
Sulfanilic acid 29 mmol/l
Hydrochloric acid 0.2 mol/l
Cetrimide 50 mmol/l
Reagent B
Sodium nitrite- 11.6 mmol/l. Stored at 15-30° C. Reagents were stable until the expiry
date shown on the label when stored tightly closed and if contaminations was avoided
during use. Presence of particulate matter, turbidity, absorbance over 0.05 at 540 nm,
indicate deterioration.
Working Reagent preparation: Mixture of 1 ml of Reagent B and 4 ml of Reagent A.
This was Stable for 20 days at 2-8° C.
Particulars Reagent Blank Sample Blank Sample Standard
Distilled water
Sample
Standard
Reagent A
Working Reagent
100 µl
--
--
--
1000 µl
--
100 µl
--
1000 µl
--
--
100 µl
--
--
1000 µl
--
--
100 µl
--
1000 µl
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 84
Mixed thoroughly and was allowed to stand for 2 min at room temperature.
Absorbance of sample blank was read at 540 nm against distilled water and
absorbance of sample was read at 540 nm against reagent blank.
Calculations
Bilirubin content in the sample =A (sample) – A (sample blank) x C (standard)
A (standard)
Mass concentration (mg/dl) x 17.1 = Substance concentration in µmol/l.
v) Total protein estimation
Principle: The enzymatic reaction sequence employed in the assay of total protein
was as follows:
Protein + Cu2+
Cu – Protein complex
(Biuret)
Total proteins were estimated using Total protein reagent from Agappe Diagnostics,
Kerala, India (Gornall, et al., 1949; Lowry, et al., 1951).
Composition of Total protein reagent
Potassium iodide- 6 mmol/l
Potassium sodium tartrate- 21 mmol/l
Copper sulphate- 6 mmol/l
Sodium hydroxide- 58 mmol/l
Total Protein Standard- 6 g/dl.
The reagent was stable for 18 months when stored at 2-8° C.
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 85
To 20 µl of serum, 1ml of total protein reagent was added and mixed. The mixture
was incubated at 37oC for 15 minutes and the absorbance was measured at 546 nm
using a Biochemical Analyzer. The protein content was calculated by using the
following formula and expressed as total protein in g/dl.
Total protein in g/dl = Absorbance of sample x C
Absorbance of standard
where C refers to the protein concentration in standard protein solution in g/dl.
vi) Albumin estimation
Principle: The reaction between albumin in serum or plasma and the dye bromocresol
green produces a change in colour, which is proportional to albumin concentration.
(Dumas, et al., 1997).
Reagent Composition
Albumin reagent
Succinate buffer (pH- 4.2) - 75 mmol/l
Bromocresol green - 0.14 g/l
Albumin Standard
Albumin Standard concentration - g/dl
The reagent is stable for 18 months when stored at 2-8o C.
Animal serum was used as sample. 10 µL of serum was mixed with 1000 µL of
reagent, mixed and incubated for 1 minute. The absorbance was measured against
blank at 630 nm.
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 86
Calculation
Albumin (g/dl) = Absorbance of sample x C
Absorbance of standard
where C refers to the albumin concentration in standard albumin solution in g/dl.
3.2 Assessment of oxidative stress in liver
i) Preparation of liver homogenates
Livers were dissected, stored at −40°C, homogenized and the homogenates were
subjected to estimation of lipid peroxidation. Liver homogenate was prepared in 0.15
M potassium chloride buffer and centrifuged at 8000 rpm for 10 minutes. The
supernatant was used for estimation of MDA.
ii) Estimation of extent of lipid peroxidation
Principle: The extent of liver lipid peroxidation was assessed by measuring the
amount of MDA. In free radical induced hepatic damage, free radicals attack PUFAs,
which results in the formation of lipid radical. The lipid radicals readily react with
molecular oxygen to produce peroxyl radicals which initiate lipid peroxidation. This
is considered as the major factor influencing the breakdown and turnover of
biomembranes. Inhibition of lipid peroxidation implies hepato-protection. The chief
secondary product of lipid peroxidation reaction is MDA. This reacts with
thiobarbituric acid to form a chromogenic adduct with two molecules of TBA, which
is a pink colored complex and can be measured at 532 nm (Chatterjee and Sil, 2006;
Maté, et al., 2000).
To 500 µl 10% w/v liver homogenate in potassium chloride buffer, 1 ml of
TBA:TCA:HCl reagent (TBA 0.38%, 15 % trichloroacetic acid and 0.25 N
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 87
hydrochloric acid in ratio 1:1:1) was added, boiled for 15 min and cooled. The
mixture was then centrifuged at 10,000 rpm for 5 min, absorbance of the supernatant
solution was measured at 532 nm against reagent blank. The MDA content was
calculated as TBARS and expressed in terms of nmol/g of tissue, using the molar
extinction co-efficient, 1.56 105 moles/cm.
Concentration of TBARS (nmol/g) = A / t
Where A = Absorbance of sample, t = Path length
= Molar extinction coefficient of MDA (1.56 105 /Moles/cm)
3.3 Histopathological investigation on liver tissues
Liver tissues were dissected out carefully and were kept in 10% formalin solution
prepared with normal saline. Histopathological studies were conducted by Dr. Kishore
Alwa, Isha Diagnostics, Malleswaram, Bangalore. Tissues were stained using
Hematoxylin and Eosin stain (H and E).
4. PARAMETERS TO ASSESS METABOLIC DISORDERS
4.1 Estimation of glucose
Principle: The substrate β-D-glucose is oxidized by glucose oxidase to from gluconic
acid and hydrogen peroxide. The hydrogen peroxide so generated oxidizes the
chromogen system consisting of 4-aminoantipyrine and phenolic compound to a red
quinoeimine dye. The intensity of the colour produced is proportional to the glucose
concentration and is measured at 505 nm (490-530 nm) or with green filter (Trinder,
1969).
Glucose + O2 Gluconic acid + H2O2
H2O2+Phenolic compound+4-Aminoantipyrine Red Quinoemine+H2O
Glucose
Oxidase Peroxidase
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 88
Kit contents
Reagent 1: Glucose reagent
Reagent 2: Glucose Standard (For calibration)
Procedure for estimation of glucose
Pipetted into micro-
centrifuge tubes Blank (µl) Standard (µl) Test (µl)
Glucose Reagent 500 500 500
Calibrator (Standard) -- 5 --
Sample (Serum) -- -- 5
Distilled water 5 -- --
Mixed and incubated at 37oC for 10 minutes. Absorbance of the Test (AT), Standard
(AS) and Reagent Blank (AB) at 505 nm was read against distilled water using
Biochemical Analyzer.
Calculations
Glucose (mg/dl) = (AT-AB/AS-AB) x100
Where 100 = Standard concentration of Glucose (mg/dl)
4.2 Estimation of lipid profile
i) Total cholesterol
Principle: Enzymatic determination of total cholesterol was performed according to
the following equation (Allain, et al., 1974).
Cholesterol ester+H2O Cholesterol + Fatty acids
Cholesterol + O2 4- Cholesten- 3- one + H2O2
2 H2O2 + Phenol + 4- aminoantipyrene Red quinine + 4H2O
Cholesterol
esterase
Cholesterol
Oxidase
Peroxidase
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 89
Cholesterol reagent
Pipes buffer, pH 6.7- 50 mmol/l
Phenol- 24 mmol/l
Sodium cholate- 0.5 mmol/l
4- aminoantipyrene- 0.5 mmol/l
Cholesterol esterase > 180 U/l
Cholesterol oxidase > 200 U/l
Peroxidase > 1000 U/l
Cholesterol standard solution 200 mg/dl
The reagent is stable for 18 months when stored at 2-8° C. Animal serum was used as
the sample.
10 µl of serum was mixed with 1000 µl of reagent, incubated for 5 min at 37 °C and
estimated at 630 nm using a Biochemical Analyzer.
Calculation
Cholesterol (mg/dl) = Absorbance of sample x 200
Absorbance of standard
ii) Triglycerides
Principle: Enzymatic determination of triglycerides was performed according to the
following equation (Schettler and Nussel, 1975).
Triglyceride + H2O Glycerol + Fatty acids
Glycerol + ATP Glycerol-3- phosphate + ADP
Glycerol-3-PO4 + O2 Dihydroxy acetone phosphate+ H2O2
Lipoprotein lipase
Glycerol kinase
Glycerol-3-
phosphate oxidase
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 90
H2O2 + 4- aminoantipyrine + p- chlorophenol Red quinoneimine
Reagent Composition
Pipes buffer, pH 7.0- 50 mmol/l
p-chlorophenol- 5.3 mmol/l
Potassium ferrocyanate- 10 mmol/l
Magnesium salt- 17 mmol/l
4- aminoantipyrine- 0.9 mmol/l
ATP- 3.15 mmol/l
Lipoprotein lipase > 1800 U/l
Glycerol kinase > 450 U/l
Glycerol-3- phosphate oxidase > 3500 U/l
Peroxidase > 450 U/l
Triglyceride standard solution- 200 mg/dl
The reagent was stable for 18 months when stored at 2-8° C.
Animal serum was used as the sample. 10 µl of serum was mixed with 1000 µl of
reagent, incubated for 5 min at 37 ° C and estimated at 630 nm using a Biochemical
Analyzer.
Calculation:
Triglyceride (mg/dl) = Absorbance of sample x 200
Absorbance of standard
iii) HDL cholesterol
Principle: The chylomicrons, VLDL and LDL of serum were precipitated by
phosphotungstic acid and magnesium ions. After centrifugation, HDL in the
supernatant solution was measured by enzymatic method (Gordon, et al., 1977).
Peroxidase
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 91
HDL cholesterol reagent
Phosphotungstate- 14 mmol/l
Magnesium chloride- 1 mmol/l
Preservative
HDL cholesterol standard- 50 mg/dl.
Animal serum was used as the sample. 300 µl of serum was mixed with 300 µl of
HDL reagent, allowed to stand for 10 min at room temperature, mixed again and
centrifuged for 10 min at 4000 rpm. After centrifugation the clear supernatant was
separated from the precipitate within 1hr and HDL was determined using cholesterol
reagent. 50 µl of supernatant was mixed with 1000 µl of cholesterol reagent,
incubated for 5 min at 37 ° C and estimated at 630 nm using a Biochemical Analyzer.
Calculation
HDL cholesterol conc (mg/dl) = Absorbance of sample x N x 2
Absorbance of standard
N= Standard concentration (50 mg/dl)
iv) Estimation of LDL
Formula
LDL = TC/1.19 + TG/1.9 – HDL/1.1 – 38 (mg/dl) (Ahmadi, et al., 2008).
v) Estimation of VLDL
Formula
VLDL = Triglycerides (mg/dl) (Ahmadi, et al., 2008).
5
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 92
5. INVESIGATION OF PHARMACOKINETIC AND PHARMACO-
DYNAMIC INTERACTIONS
5.1 Maximal electroshock induced seizures (MES)
Electroconvulsions were induced by ear electrodes (current intensity-150 mA,
duration - 0.2 sec). The animals were observed for tonic hind limb extension i.e., the
hind limbs of animals outstretched 180° to the plane of the body axis (Kulkarni,
1999).
5.2 Estimation of plasma carbamazepine concentration by HPLC method
i) Chromatographic conditions
Mobile phase consisting of acetonitrile: water (30:70 v/v) was prepared and mixed
thoroughly, degassed and was used for the HPLC analysis. 1.0 ml per minute flow
rate was maintained throughout the analysis. The eluent was monitored using a UV-
VIS detector set at 270 nm and sensitivity was set at 0.001 a.u.f.s (Demrikaya and
Kadioglu, 2005).
ii) Preparation of standard graph
a) Standard solutions
Stock solution of 100 µg/ml of CBZ was prepared in methanol and diluted with
methanol to the required concentration. The solutions were stored at –4ºC. For the
preparation of standard graph 2, 4, 6, 8, 10, 12, 14, 16, 18 20 µg/ml of pure CBZ was
used.
Material and Methods
Institute of Pharmaceutical Technology, SPMVV, Tirupati 93
b) Plasma extraction procedure
To each 100 µl of plasma sample, 25 µl of internal standard (100 µg/ml phenytoin
solution) was added and extracted with 1.7 ml of ethyl acetate, vortexed for 1 min and
centrifuged at 13,000 rpm for 8 min. The supernatant was evaporated to dryness and
the residue was reconstituted with 100 µl of mobile phase, vortexed for 1 min. and 20
µl was injected onto C18 column. The retention times were 3.673 min and 6.065 min
for carbamazepine and phenytoin respectively. The peak area obtained at different
concentrations of the drug was plotted against the concentrations of the drug (Garg, et
al., 1999; Chen, et al., 2001).
STATISTICAL ANALYSIS
The results were expressed as mean ± S.E.M (n=6). The statistical analysis was
performed by means of ANOVA followed by Tukey-Kramer's Multiple Comparison
Test. P value < 0.05 was considered as statistically significant. Data was processed
with Graph Pad Instat software.